JINCY EAPEN: Open Payments
NPI 1588299598 · WHEELING, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$245 in 12 payments from 7 companies in 2025. Trend: 2023 $142 · 2024 $568 · 2025 $245
Food & beverage: $245
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $99 |
| Aimmune Therapeutics, Inc. | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| Novo Nordisk Inc | 1 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| ABBVIE INC. | 1 | $22 |
| Madrigal Pharmaceuticals | 1 | $21 |
Products named: ENTYVIO, ZENPEP, VOQUEZNA, Wegovy, IQIRVO, LINZESS, REZDIFFRA.
Industry payments across IL — which companies pay providers there.
